Uncategorized

Viatris recalls extended-release Xanax over dissolution test failure

Published

on

Viatris, which Pfizer created in 2020, voluntarily withdrew extended-release products made at a plant in Ireland after an analysis revealed an issue that could affect bioavailability.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version